How to manage waldenstrom's macroglobulinemia in 2024.
Grunenberg A, Buske C.
Cancer Treat Rev. 2024 Apr;125:102715. doi: 10.1016/j.ctrv.2024.102715. Epub 2024 Mar 5.
Waldenstrom's macroglobulinaemia.
[No authors listed]
Lancet. 1985 Aug 10;2(8450):311-2.
[Waldenstrom's disease].
Fernández García E, Fernández Blasco E.
Rev Clin Esp. 1965 Jun 30;97(6):413-5.
Pathophysiology of Waldenstrom's macroglobulinemia.
Stone MJ, Pascual V.
Haematologica. 2010 Mar;95(3):359-64. doi: 10.3324/haematol.2009.017251.
Managing complications secondary to Waldenstrom's macroglobulinemia.
Pessach I, Dimopoulos MA, Kastritis E.
Expert Rev Hematol. 2021 Jul;14(7):621-632. doi: 10.1080/17474086.2021.1947236. Epub 2021 Jul 2.
Uveal effusion in Waldenstrom's macroglobulinemia.
Darmon J, Anjou M, Georgelin D, Brezin AP, Bremond-Gignac D.
Retin Cases Brief Rep. 2024 Jul 19;19(5):612-4. doi: 10.1097/ICB.0000000000001631. Online ahead of print.
Monoclonal antibody-based therapies for Waldenstrom's macroglobulinemia.
Fotiou D, Theodorakakou F, Kastritis E.
Leuk Res Rep. 2022 May 6;17:100324. doi: 10.1016/j.lrr.2022.100324. eCollection 2022.
The Management of Relapsed or Refractory Waldenstrom's Macroglobulinemia.
García-Sanz R, Tedeschi A.
Hematol Oncol Clin North Am. 2023 Aug;37(4):727-749. doi: 10.1016/j.hoc.2023.04.006. Epub 2023 May 26.
Waldenstrom's macroglobulinemia.
Deuel TF, Davis P, Avioli LV.
Arch Intern Med. 1983 May;143(5):986-8.
[Waldenstrom's macroglobulinemia].
PICONE C.
G Clin Med. 1960 Jan;41:28-60.
